Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Susuxiaoer Zhike Granules for Pediatric Common Cold Cough (Wind-cold pattern)
CTR20192628Phase 2Completed
- Sponsor
- Wuhan Pharmaceutical Valley Technology Development
- Start
- Jan 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Susuxiaoer Zhike Granules in nasopharyngitis, acute cough, sponsored by Wuhan Pharmaceutical Valley Technology Development. Started Jan 2020; status: completed.
02
Drugs
Susuxiaoer Zhike Granules
03
Conditions
nasopharyngitisacute cough
Beyond the preview
Go deeper on CTR20192628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192628.